To view this email as a web page, click here

   Home

Subscribe

Advertise

 

 

 

 

June 21, 2019___

Today's Rundown

Featured Story

From prison, Shkreli sues—and settles with—Retrophin executives

Martin Shkreli settled a lawsuit he filed against his former Retrophin colleagues, claiming they “unceremoniously and illegally” ousted him in 2014. He had sought more than $30 million in damages.

Top Stories

Sanofi, Regeneron asthma prospect struggles against Dupixent

A phase 2 asthma trial of Sanofi and Regeneron’s REGN3500 has met its primary endpoint. But the IL-33 antibody performed numerically worse than Dupixent and showed little promise in combination with the approved drug.

Recursion names Theravance veteran as CSO

Recursion has named Sharath Hegde as its chief scientific officer. The appointment ends a 20-year stint at Theravance Biopharma and its parent company that culminated in Hegde rising to head of research.

How a long-known biomarker backs BioNTech's antibody for pancreatic cancer

A team of scientists at Cold Spring Harbor Laboratory has found that blocking CA19-9 in rodents can serve as a therapeutic strategy to prevent the progression from chronic pancreatitis to pancreatic cancer. A drug being developed by German biotech BioNTech is designed to do just that and has proven promising in an early human trial.

EuroBiotech Report—Sanofi cuts, AZ in Korea, uniQure M&A, U.K. and BerGenBio

In this week's EuroBiotech Report, Sanofi cuts staff in R&D rejig, AstraZeneca bets on Korea and uniQure weighs buyout bids.

FiercePharmaAsia—Japan's global first nods; Celgene hands back PD-1; China's copycat invite

Japan grants global first nods to drugs from Roche, Daiichi Sankyo and AstraZeneca. Celgene hands back PD-1 to BeiGene amid Bristol-Myers merger. China is soliciting copycats to a list of 34 drugs, offering priority review. And more.

Chutes & Ladders—Merck scouts for CEO replacements after scrapping retirement rule

Merck scouts CEO replacement; Flatiron Health nabs biopharma vet; and ex-Medicines Company exec lands at antifungal specialist Scynexis. Those moves plus more hirings, firings and retirings throughout the industry.

Resources

[Whitepaper] The essential guide to managing laboratory samples

This Essential Guide to Managing Laboratory Samples is a three-part piece exploring common problems experienced in the management of samples and how, for any scale of operation, significant efficiency and accuracy benefits can be gained using dedicated sample management software.

[Whitepaper] Satisfying GxP Requirements Using the Internet of Things (IoT)

How can the Internet of Things (IoT) enable you to meet GxP?

[Whitepaper] Managing Comorbidities in Type 2 Diabetes – Real World Evidence for Change

Patients living with diabetes deserve better – Real-World Evidence for effecting/realizing change in the management of type 2 diabetes and cardiovascular/renal comorbidities.

[Webinar] Why do US sponsors come to Russia? New options for clinical trials.

Fast and cost-efficient patient-enrollment,100% success strategy for obtaining a CTA, unified market authorization across the EEU countries. Find out the key compelling reasons to conduct studies in Russia.

[Whitepaper] Agile Competitive Intelligence Strategies For Healthcare

What is agile competitive intelligence, and how can it help take market research to the next level?

[POCKET GUIDE] Reference and Literature Management Made Easy

Get 5 quick tips for faster research and better results!

[Report] Precision medicine from concept to clinic

In this publication, Blue Latitude Health maps the journey of stakeholders impacted by the rise of precision medicine today. Download the report.

[Whitepaper] Flow Chemistry: A Scale-Up Solution for Modern API Development & Manufacturing

Increase Safety & Flexibility with Flow Chemistry

[On-Demand Webinar] Lessons Learned Implementing an End-to-End RIM Solution

IONIS shares best practices for implementing an end-to-end RIM solution in this on-demand webinar. Watch now.

[Whitepaper] Site-specific, Patient-centered and Whip-smart: Enrollment Assistants Adapt to a Shifting Landscape

Increasingly complex clinical trials place a tremendous burden on study sites, exacerbating already-troubling recruitment and enrollment issues. Overwhelmed, many sites may not be up to the task or have the appropriate infrastructure, creating costly delays that keep new therapies from patients.

[Case Study] Clinical Supply Management

Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study.

[Video] Demand Led Services and Clinical Supply Efficiency

Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels.

[eBook] Strategies for Efficient Clinical Supply Management and Forecasting

Download the eBook to explore a proactive approach for clinical supply management.

Events